When an LVAD (left ventricular assist device) fails, the heart loses the mechanical support it depends on to pump blood effectively. Because LVAD patients have severe heart failure, their native heart typically cannot compensate on its own, and blood flow to the brain, kidneys, and other organs drops rapidly. This is a life-threatening emergency that requires immediate action from the patient, their caregiver, and medical teams.
What Happens Inside the Body
An LVAD works by continuously pulling blood from the weakened left ventricle and pushing it into the aorta, essentially doing the pumping work the heart can no longer manage. When the device stops or slows significantly, forward blood flow drops and pressure backs up into the lungs and veins. The result is a rapid return of heart failure symptoms, sometimes within minutes.
Reduced blood flow to the brain causes dizziness, confusion, and in severe cases, loss of consciousness. The lungs begin to fill with fluid, producing sudden shortness of breath. Blood pressure falls, and the body starts showing signs of shock: cold, clammy skin, rapid breathing, and extreme fatigue. If the pump stops completely and the native heart is too weak to generate meaningful output, organs can begin to shut down. Acute kidney injury is one of the earliest consequences of prolonged low flow.
In cases where a blood clot inside the pump (pump thrombosis) is the cause, additional problems emerge. The clot shears red blood cells as they pass through, destroying them in a process called hemolysis. Patients may develop visible pallor, dark urine from the breakdown products, and worsening signs of congestion like swollen legs, elevated neck veins, and fluid retention.
Why LVADs Fail
LVAD failure isn’t a single event. It can stem from several different problems, each with its own timeline and severity.
- Pump thrombosis: A blood clot forms inside the pump mechanism, partially or fully blocking flow. This is one of the most dangerous complications. It can develop gradually, with rising warning signs, or progress quickly into hemodynamic collapse. Newer devices like the HeartMate 3 have reduced thrombosis rates, but the risk hasn’t been eliminated entirely.
- Driveline damage: The driveline is the cable that runs from the internal pump through the skin to the external controller and batteries. In a large study of roughly 1,200 devices, the driveline fracture rate was 9.2%. Most of these (87%) involved the external portion of the cable and could be repaired without surgery. But if the internal portion of the cable or the pump itself is damaged, profound cardiogenic shock can develop, and emergency surgical intervention becomes necessary.
- Power loss: LVADs run on external batteries connected through the controller. If both batteries die, become disconnected, or the controller malfunctions, the pump stops. Patients carry backup batteries for this reason, but a complete power interruption halts blood flow support immediately.
- Controller malfunction: The controller is the small computer that regulates pump speed and monitors performance. A software error or hardware failure here can alter pump output or shut the device down entirely.
Warning Signs of a Failing LVAD
The LVAD controller is designed to alert patients and caregivers when something goes wrong. A flashing red heart symbol on the controller screen indicates low flow or pump stoppage. This is the most urgent alarm the system produces and requires emergency medical attention. The controller screen will display instructions, but the immediate priority is getting to an emergency room, ideally at the center where the device was implanted.
Beyond alarms, patients may notice physical warning signs before a full failure occurs. Increasing shortness of breath, new or worsening dizziness, unusual fatigue, and swelling in the legs or abdomen all suggest the pump isn’t delivering enough blood. Some patients notice a return of the symptoms they had before the LVAD was placed. A new palpable pulse (LVAD patients typically have a very faint or absent pulse because the pump provides continuous flow rather than pulsing) can indicate the native heart is working harder to compensate for a struggling device, which is another red flag.
What Caregivers Should Do
Every LVAD patient has a trained caregiver, and that person’s role becomes critical during a device emergency. When a red heart alarm sounds or the patient shows signs of distress, the first step is checking the controller screen for specific instructions. Common immediate actions include switching to backup batteries, checking that all cable connections are secure, and making sure the driveline isn’t kinked, twisted, or pulled.
If the problem can’t be resolved at home, the patient needs urgent transport to an emergency room. Key guidelines during transport: bring all LVAD equipment (backup controller, batteries, chargers), keep the caregiver with the patient at all times, and avoid pulling or kinking the driveline when moving or strapping the patient to a stretcher. If possible, transport to the implanting center, where the surgical and VAD coordination teams are familiar with the patient’s device and history.
CPR and LVADs
One of the most confusing situations for bystanders and even some emergency responders is whether to perform chest compressions on an LVAD patient. The American Heart Association’s guidelines make a clear distinction: if the patient is unresponsive but still has adequate perfusion (meaning blood is still flowing sufficiently), chest compressions should not be performed. The pump is still working, and compressions could damage the device or the internal connections.
If the patient is unresponsive and does not have adequate perfusion, chest compressions should be performed. In this scenario, the pump has either stopped or is not generating enough flow to sustain life, and the benefit of compressions outweighs the risk. Checking for a pulse on an LVAD patient is unreliable because many LVAD patients don’t have a detectable pulse even when the device is functioning normally. Blood pressure measured with a Doppler ultrasound, level of consciousness, and the controller readout are more useful indicators.
Emergency Treatment and Pump Exchange
At the hospital, the immediate goal is stabilizing blood flow. If the pump has stopped or is severely compromised, medications that strengthen the heart’s own contractions can help bridge the gap temporarily. The VAD team will assess whether the pump can be restarted, whether a clot can be treated with blood thinners, or whether a surgical pump exchange is needed.
Pump exchange, where the failed device is surgically replaced with a new one, carries risk but has encouraging survival numbers. In one study, the one-year survival rate after LVAD exchange was 93%, compared to 76% in a similar group of patients who did not undergo exchange. One significant caveat: patients who’ve had a pump exchange face roughly three times the odds of developing pump thrombosis again in the replacement device. In some cases, if the patient is eligible, the team may pursue an urgent heart transplant instead of another device.
Long-Term Outlook With Current Devices
Modern LVADs, particularly the HeartMate 3, have improved reliability compared to earlier models. Data from the ELEVATE registry, tracking HeartMate 3 patients over five years, found that the rate of survival free of stroke, pump thrombosis, or major bleeding was 43.8% at the five-year mark. That means more than half of patients experienced at least one of these serious complications over five years, but the devices are keeping people alive for significantly longer than they would survive without support.
The reality for LVAD patients is that device failure is a known risk that requires constant vigilance. Carrying charged backup batteries, protecting the driveline from damage, keeping follow-up appointments, and ensuring a trained caregiver is always accessible are the practical measures that reduce the chance of a failure becoming fatal. When problems are caught early through alarms, symptom awareness, or routine monitoring, outcomes are substantially better than when failure progresses to full hemodynamic collapse.